occurs in has participant quality has disease treated with drug FLUVASTATIN ROPINIROLE SILDENAFIL ESZOPICLONE INDOMETHACIN CIPROFLOXACIN HYDROCHLORIDE MISOPROSTOL BETAXOLOL CLOMIPRAMINE DOXORUBICIN FLUOXETINE PERGOLIDE SELEGILINE TOLMETIN RITONAVIR ROFECOXIB VALDECOXIB VARDENAFIL TADALAFIL TINIDAZOLE RASAGILINE TELBIVUDINE hypertension gastric ulcer obsessive-compulsive disorder bulimia nervosa acute cystitis Parkinson's disease major depressive disorder impotence trichomoniasis hepatitis B ovarian cancer human immunodeficiency virus infectious disease sleep disorder panic disorder congestive heart failure migraine pulmonary hypertension rheumatoid arthritis osteoarthritis amebiasis Elderly Child Adult Adolescent dyspepsia AE 10013946 CTCAE: E10617 NCIt: C26756 Dyspepsia is popularly known as indigestion, meaning hard or difficult digestion. It is a medical condition characterized by chronic or recurrent pain in the upper abdomen, upper abdominal fullness and feeling full earlier than expected when eating. YH HPO: HP_0002577 an abnormal digestion AE which has an outcome of dyspepsia According to the Vaccine Adverse Event Reporting System (VAERS), 'dyspepsia' is an adverse event that was mentioned in 454 VAERS reports (0.4%) during1991-2001 (Reference: PMID: 12825543). SIDER: C0013395 abnormal digestion AE AE severity G1 AE severity G2 AE severity G3